Evidence map›Paper›PMID 23476655›Full record

ArticleJournal of probability and statistics2012

Predicting Disease Onset from Mutation Status Using Proband and Relative Data with Applications to Huntington's Disease.

Tianle Chen, Yuanjia Wang, Yanyuan Ma, Karen Marder, Douglas R Langbehn

Open access · goldAbstract read
In one paragraph

Article in Journal of probability and statistics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Sample enrichment for clinical trials to show delay of onset in huntington disease.Movement disorders : official journal of the Movement Disorder Society · 2019
    Trial
  2. Article
  3. Article
  4. Article
  5. Age of Onset of Huntington's Disease in Carriers of Reduced Penetrance Alleles.Movement disorders : official journal of the Movement Disorder Society · 2021
    Observational
  6. Statistical modeling of Huntington disease onset.Handbook of clinical neurology · 2017
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Tianle ChenDepartment of Biostatistics, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.
Yuanjia Wang
Yanyuan Ma
Karen Marder
Douglas R Langbehn
Columbia University · USColumbia University Irving Medical Center · USTexas A&M University · USUniversity of Iowa · US

Funding

Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Functional Data Analysis of Longitudinally Measured Genetic Traits.R03AG031113 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2009 to 2010
$132k
NIA NIH HHS R03 AG031113NINDS NIH HHS R01 NS073671
6 · The paper itself

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disorder caused by an expansion of CAG repeats in the IT15 gene. The age-at-onset (AAO) of HD is inversely related to the CAG repeat length and the minimum length thought to cause HD is 36. Accurate estimation of the AAO distribution based on CAG repeat length is important for genetic counseling and the design of clinical trials. In the Cooperative Huntington's Observational Research Trial (COHORT) study, the CAG repeat length is known for the proband participants. However, whether a family member shares the huntingtin gene status (CAG expanded or not) with the proband is unknown. In this work, we use the expectation-maximization (EM) algorithm to handle the missing huntingtin gene information in first-degree family members in COHORT, assuming that a family member has the same CAG length as the proband if the family member carries a huntingtin gene mutation. We perform simulation studies to examine performance of the proposed method and apply the methods to analyze COHORT proband and family combined data. Our analyses reveal that the estimated cumulative risk of HD symptom onset obtained from the combined data is slightly lower than the risk estimated from the proband data alone.

Identifiers

PMID23476655
PMCPMC3589804
OpenAlexW1992773553

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.